TNFR1 and TNFR2 Expression and Induction on Human Treg Cells from Type 1 Diabetic Subjects
| Autor: | Elise Hsu, Denise L. Faustman, Danielle Baum, Peter E Reinhold, Sarah Warden, Limei Wang, Menghan Zhao, Georges Tahhan, Douglas E. Burger, Melanie Heinrich |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2015 |
| Předmět: |
lcsh:Immunologic diseases. Allergy
medicine.medical_specialty type 1 diabetes Immunology Cell chemical and pharmacologic phenomena Biology medicine.disease_cause Treg cell Autoimmunity Internal medicine Drug Discovery medicine Immunology and Allergy Receptor Autoimmune disease Type 1 diabetes Multiple sclerosis autoimmunity hemic and immune systems medicine.disease TNFR2 Endocrinology medicine.anatomical_structure Tumor necrosis factor alpha T regulatory cells (Treg) lcsh:RC581-607 |
| Zdroj: | Antibodies, Vol 4, Iss 1, Pp 34-47 (2015) Antibodies Volume 4 Issue 1 Pages 34-47 |
| ISSN: | 2073-4468 |
| Popis: | Several autoimmune diseases are marked by a deficiency of soluble tumor necrosis factor (TNF). The TNF deficiency is caused in at least one autoimmune disease, multiple sclerosis, by an overabundance of TNF receptor 1 (TNFR1). Excess TNFR1 binds and inactivates TNF and this leaves less TNF bioavailable. This study sought to determine if expression of fresh or IL2-stimulated TNF receptors on Tregs cells, an important immunoregulatory cell involved in autoimmunity, is altered in type I diabetes. Standard fluorescence analysis was used to examine the levels of TNFR1 and TNFR2 on human Tregs in patients with type I diabetes (T1D) or controls. Fresh Tregs from T1D compared to control Tregs had identical levels of TNFR1. In marked contrast, Type 1 diabetic patients Treg cells had statistically elevated levels of TNFR2 compared to controls. Tregs stimulated with IL2 from both T1D and controls showed marked increase of TNFR2 expression in a dose-response manner, but the dose response increase in TNFR2 was significantly higher for T1D Treg cells. No IL2 dose-response was present for TNFR1 on either T1D or control Tregs exposed to IL2. A large study of serum for secreted levels of TNFR2 also revealed elevated circulating levels consistent with the elevated surface expression on Tregs. These findings suggest that abnormal regulation of TNFR2 expression with elevated cellular and secreted levels of TNFR2 is a characteristic of Type 1 diabetes. It is possible that the relative deficiency of TNF in type I diabetes, in contrast to multiple sclerosis, is caused by excess expression of TNFR such as TNFR2, a binding structure for inactivating TNF. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|